[ad_1]
In recent days, a chain of European countries has frozen use of the drug after reports that a small number of vaccinated people have developed blood clots.
“We have decided to temporarily suspend the use of this vaccine for at least the next two weeks,” Minister Carolina Darias told reporters. Germany, France and Italy announced similar steps on Monday.
According to Darius, the AstraZeneca vaccine will not be vaccinated in Spain until the European Medicines Agency (EMA) “analyzes recent blood clots. [susidarymo] cases, especially last weekend ”.
On Friday, at least five regions of Spain announced a preventive stop in vaccination against AstraZeneca.
The Amsterdam-based EVA said it still thought the vaccine, developed by British and Swedish companies in conjunction with the University of Oxford, was safe to use, but that it would hold a special meeting on Thursday to decide on “further action.” about the topic.
Marco Cavaleri, head of the agency’s vaccine strategy unit, told the European Parliament Health Committee on Monday: “We are looking at all the data, especially the deaths that have been reported.”
However, he added that the EVA “will see no problem in continuing the vaccination campaign with this vaccine.”
According to the EVA, suspected side effects included blood clots and sometimes “unusual features” were seen, such as low levels of platelets, the cells that cause blood to clot.
However, the agency emphasized that such a reaction occurred “only in a very small number of people who received the vaccine.”
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
